{"transactions":[{"id":3403677,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-10-01T22:45:04.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":4958,"price":28.63,"value":141947.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":160636,"source":{"system":"sec-edgar","filing":"0001628656-19-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000009/edgardoc.xml","form_type":"4"}},{"id":3403676,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-10-01T22:45:04.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":6149,"price":28.63,"value":176045.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":165594,"source":{"system":"sec-edgar","filing":"0001628656-19-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000009/edgardoc.xml","form_type":"4"}},{"id":3406022,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-09-26T21:12:21.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":4958,"price":29.93,"value":148392.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":171743,"source":{"system":"sec-edgar","filing":"0001628656-19-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000007/edgardoc.xml","form_type":"4"}},{"id":3406021,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-09-26T21:12:21.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":4339,"price":29.93,"value":129866.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":176701,"source":{"system":"sec-edgar","filing":"0001628656-19-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000007/edgardoc.xml","form_type":"4"}},{"id":3406020,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-09-26T21:12:21.000Z","date":"2019-09-25","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023."}],"balance_after":181040,"source":{"system":"sec-edgar","filing":"0001628656-19-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000007/edgardoc.xml","form_type":"4"}},{"id":3449956,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-08-02T20:40:42.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":11712,"price":40,"value":468480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":146040,"source":{"system":"sec-edgar","filing":"0001628656-19-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000005/edgardoc.xml","form_type":"4"}},{"id":3710743,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2019-01-03T18:20:38.000Z","date":"2019-01-02","kind":"disposition_to_issuer","acquired":false,"shares":3734,"price":29,"value":108286.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":157752,"source":{"system":"sec-edgar","filing":"0001628656-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865619000002/edgardoc.xml","form_type":"4"}},{"id":3803013,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2018-10-02T13:05:07.000Z","date":"2018-09-30","kind":"disposition_to_issuer","acquired":false,"shares":6149,"price":46,"value":282854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":161486,"source":{"system":"sec-edgar","filing":"0001628656-18-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865618000008/edgardoc.xml","form_type":"4"}},{"id":3803012,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2018-10-02T13:05:07.000Z","date":"2018-09-30","kind":"disposition_to_issuer","acquired":false,"shares":4958,"price":46,"value":228068.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":167635,"source":{"system":"sec-edgar","filing":"0001628656-18-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865618000008/edgardoc.xml","form_type":"4"}},{"id":3807843,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2018-09-26T18:27:05.000Z","date":"2018-09-25","kind":"disposition_to_issuer","acquired":false,"shares":4958,"price":46.65,"value":231290.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":172593,"source":{"system":"sec-edgar","filing":"0001628656-18-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865618000006/edgardoc.xml","form_type":"4"}},{"id":3810154,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2018-09-21T16:25:08.000Z","date":"2018-09-19","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022."}],"balance_after":177551,"source":{"system":"sec-edgar","filing":"0001628656-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865618000004/edgardoc.xml","form_type":"4"}},{"id":4114401,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2018-01-04T00:39:15.000Z","date":"2018-01-02","kind":"disposition_to_issuer","acquired":false,"shares":3621,"price":34.91,"value":126409.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":142551,"source":{"system":"sec-edgar","filing":"0001628656-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865618000002/edgardoc.xml","form_type":"4"}},{"id":4196110,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2017-10-03T21:20:48.000Z","date":"2017-09-30","kind":"disposition_to_issuer","acquired":false,"shares":5218,"price":36.18,"value":188787.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":146172,"source":{"system":"sec-edgar","filing":"0001628656-17-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865617000006/edgardoc.xml","form_type":"4"}},{"id":4196109,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2017-10-03T21:20:48.000Z","date":"2017-09-30","kind":"disposition_to_issuer","acquired":false,"shares":6472,"price":36.18,"value":234156.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":151390,"source":{"system":"sec-edgar","filing":"0001628656-17-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865617000006/edgardoc.xml","form_type":"4"}},{"id":4208754,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2017-09-15T20:46:10.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021."}],"balance_after":157862,"source":{"system":"sec-edgar","filing":"0001628656-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865617000004/edgardoc.xml","form_type":"4"}},{"id":4504769,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2017-01-04T18:22:29.000Z","date":"2017-01-03","kind":"disposition_to_issuer","acquired":false,"shares":2631,"price":16.93,"value":44542.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":116360,"source":{"system":"sec-edgar","filing":"0001628656-17-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865617000002/edgardoc.xml","form_type":"4"}},{"id":4590911,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2016-10-03T22:08:39.000Z","date":"2016-09-30","kind":"disposition_to_issuer","acquired":false,"shares":4661,"price":20.58,"value":95923.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":118991,"source":{"system":"sec-edgar","filing":"0001628656-16-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865616000008/edgardoc.xml","form_type":"4"}},{"id":4601995,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2016-09-16T18:03:35.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020."}],"balance_after":126220,"source":{"system":"sec-edgar","filing":"0001628656-16-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865616000006/edgardoc.xml","form_type":"4"}},{"id":4601994,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":154673,"kind":"person","name":"Tobin Bernard","position":1,"cik":"0001628656","reported_name":"Tobin Bernard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Crescendo BioScience"}}],"security":"Common Stock","published_at":"2016-09-16T18:03:35.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":49608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan.  Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019."}],"balance_after":86220,"source":{"system":"sec-edgar","filing":"0001628656-16-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162865616000006/edgardoc.xml","form_type":"4"}}]}